Showing results (711-720 of 798) with videos related to

Sort By:
Pageof 80
Leukemia Research|August 13, 2022
CD123-directed allogeneic chimeric-antigen receptor T-cell therapy (CAR-T) in blastic plasmacytoid dendritic cell neoplasm (BPDCN): Clinicopathological insightsNaveen Pemmaraju, Nathaniel R Wilson, Jayastu Senapati, et al.
Cells|August 12, 2022
β-Glucocerebrosidase Deficiency Activates an Aberrant Lysosome-Plasma Membrane Axis Responsible for the Onset of NeurodegenerationGiulia Lunghi, Emma Veronica Carsana, Nicoletta Loberto, et al.
Frontiers in Oncology|October 20, 2025
Case Report: Could genetic factors influence the outcomes of first-line enfortumab vedotin plus pembrolizumab therapy in patients with metastatic urothelial carcinoma? Two cases of patients harbouring a BRCA mutationGiuseppe Salfi, Chiara Maria Agrippina Clerici, Giovanna Pecoraro, et al.
Plos One|April 25, 2024
One-instrument, objective microsatellite instability analysis using high-resolution meltKamilla Kolding Bendixen, Sofie Forsberg-Pho, Giulia Dazio, et al.
Oncogene|April 12, 2011
OTX1 expression in breast cancer is regulated by p53A Terrinoni, I S Pagani, I Zucchi, et al.
Plos One|February 9, 2023
Detection of BRAF mutations in malignant melanoma and colorectal cancer by SensiScreen® FFPE BRAF qPCR assayAnna Lahn Sørensen, Mariann Guldmann-Christensen, Michael Børgesen, et al.
Genes|November 25, 2023
Donor Cell Acute Myeloid Leukemia after Hematopoietic Stem Cell Transplantation for Chronic Granulomatous Disease: A Case Report and Literature ReviewGiovanni Micheloni, Annalisa Frattini, Marta Donini, et al.
Cerebellum (London, England)|February 23, 2021
Clinical and radiological correlates of activities of daily living in cerebellar atrophy caused by PMM2 mutations (PMM2-CDG)Fabio Pettinato, Giovanni Mostile, Roberta Battini, et al.
British Journal of Cancer|November 26, 2009
Prognostic and predictive value of TOPK stratified by KRAS and BRAF gene alterations in sporadic, hereditary and metastatic colorectal cancer patientsI Zlobec, F Molinari, M Kovac, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 3, 2011
Increased detection sensitivity for KRAS mutations enhances the prediction of anti-EGFR monoclonal antibody resistance in metastatic colorectal cancerFrancesca Molinari, Lara Felicioni, Michela Buscarino, et al.
Pageof 80